The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study
Phenylketonuria (PKU) is a metabolic disorder leading to a deficiency in the metabolism of phenylalanine (Phe). Elevated Phe levels in the blood, tissue and brain may lead to emotional, cognitive, and physical symptoms in adults. To control blood Phe levels, most individuals with PKU need to follow...
Gespeichert in:
Veröffentlicht in: | The European journal of health economics 2022-08, Vol.23 (6), p.993-1005 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1005 |
---|---|
container_issue | 6 |
container_start_page | 993 |
container_title | The European journal of health economics |
container_volume | 23 |
creator | Olofsson, Sara Gralén, Katarina Hoxer, Christina Okhuoya, Paul Persson, Ulf |
description | Phenylketonuria (PKU) is a metabolic disorder leading to a deficiency in the metabolism of phenylalanine (Phe). Elevated Phe levels in the blood, tissue and brain may lead to emotional, cognitive, and physical symptoms in adults. To control blood Phe levels, most individuals with PKU need to follow a strict, life-long Phe-restricted diet. The main objective of this study was to estimate the impact of PKU-related disease symptoms and dietary restrictions on health-related quality of life (HRQoL). This study was designed as a web-based survey using the methods of Time Trade-Off (TTO) and Discrete Choice Experiment with duration (DCE
TTO
) in a survey of the Swedish general population and population with PKU. Data were collected using questionnaires for TTO diet (
n
= 509), TTO symptoms (
n
= 507), and DCE
TTO
(
n
= 1117). The disutility of diet restrictions ranged from 0.050 for a partially restricted diet without medical food to 0.193 for a fully restricted diet with medical food in the TTO (DCE: 0.043–0.108). The disutility of experiencing symptoms (emotional, cognitive and physical) ranged from 0.148 for mild symptoms to 0.593 for severe symptoms in the TTO (DCE: 0.122–1.522). The study shows that both diet and symptoms have a significant negative impact on HRQoL in PKU and that utility estimates are largely consistent across methods and samples. |
doi_str_mv | 10.1007/s10198-021-01415-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2604467449</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2692478443</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-26cd7bc3a5e541e6f29a9ab1a7c2e559a8ca9bb9993bd6bff50970c39cf60af93</originalsourceid><addsrcrecordid>eNp9kcFu1zAMxisEEmPwApwiceFSlqRp2nBDE4NJk7iMc-SmDv-MNumSVNCX4VlJKdMkDpxs2T9_tvVV1WtG3zFKu4vEKFN9TTmrKROsrdWT6oxJ1tedpOzpQ96q_nn1IqU7SjnveHNW_bo9IXHzAiaT4Mn9CpPLGwmWTM7iHkeHmURMOTqTXfCJgB9LNSEkJGmblxzmUkwpGAcZR_LD5RNZTui36Tvm4Nfo4D0Bkt2MJEcYsQ7WPsiYiBmJOQVnkODPBWPBfCYpr-P2snpmYUr46m88r75efby9_FzffPl0ffnhpjZC8FxzacZuMA202AqG0nIFCgYGneHYtgp6A2oYlFLNMMrB2paqjppGGSspWNWcV28P3SWG-7U8q-dyGU4TeAxr0lxSIWQnxI6--Qe9C2v05bpCKS66XoimUPygTAwpRbR6KX9B3DSjerdMH5bpYpn-Y5nepckxhCZ4lx5HeqYkbVW36zYHkkrTf8P4uP0_wr8BU2Snsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2692478443</pqid></control><display><type>article</type><title>The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study</title><source>SpringerNature Journals</source><creator>Olofsson, Sara ; Gralén, Katarina ; Hoxer, Christina ; Okhuoya, Paul ; Persson, Ulf</creator><creatorcontrib>Olofsson, Sara ; Gralén, Katarina ; Hoxer, Christina ; Okhuoya, Paul ; Persson, Ulf</creatorcontrib><description>Phenylketonuria (PKU) is a metabolic disorder leading to a deficiency in the metabolism of phenylalanine (Phe). Elevated Phe levels in the blood, tissue and brain may lead to emotional, cognitive, and physical symptoms in adults. To control blood Phe levels, most individuals with PKU need to follow a strict, life-long Phe-restricted diet. The main objective of this study was to estimate the impact of PKU-related disease symptoms and dietary restrictions on health-related quality of life (HRQoL). This study was designed as a web-based survey using the methods of Time Trade-Off (TTO) and Discrete Choice Experiment with duration (DCE
TTO
) in a survey of the Swedish general population and population with PKU. Data were collected using questionnaires for TTO diet (
n
= 509), TTO symptoms (
n
= 507), and DCE
TTO
(
n
= 1117). The disutility of diet restrictions ranged from 0.050 for a partially restricted diet without medical food to 0.193 for a fully restricted diet with medical food in the TTO (DCE: 0.043–0.108). The disutility of experiencing symptoms (emotional, cognitive and physical) ranged from 0.148 for mild symptoms to 0.593 for severe symptoms in the TTO (DCE: 0.122–1.522). The study shows that both diet and symptoms have a significant negative impact on HRQoL in PKU and that utility estimates are largely consistent across methods and samples.</description><identifier>ISSN: 1618-7598</identifier><identifier>EISSN: 1618-7601</identifier><identifier>DOI: 10.1007/s10198-021-01415-9</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Blood ; Diet ; Dietary restrictions ; Economic Policy ; Health Care Management ; Health Economics ; Medical foods ; Medicine ; Medicine & Public Health ; Metabolic disorders ; Original Paper ; Pharmacoeconomics and Health Outcomes ; Phenylketonuria ; Public Finance ; Public Health ; Quality of life</subject><ispartof>The European journal of health economics, 2022-08, Vol.23 (6), p.993-1005</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-26cd7bc3a5e541e6f29a9ab1a7c2e559a8ca9bb9993bd6bff50970c39cf60af93</citedby><cites>FETCH-LOGICAL-c442t-26cd7bc3a5e541e6f29a9ab1a7c2e559a8ca9bb9993bd6bff50970c39cf60af93</cites><orcidid>0000-0003-2609-2065</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10198-021-01415-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10198-021-01415-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Olofsson, Sara</creatorcontrib><creatorcontrib>Gralén, Katarina</creatorcontrib><creatorcontrib>Hoxer, Christina</creatorcontrib><creatorcontrib>Okhuoya, Paul</creatorcontrib><creatorcontrib>Persson, Ulf</creatorcontrib><title>The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study</title><title>The European journal of health economics</title><addtitle>Eur J Health Econ</addtitle><description>Phenylketonuria (PKU) is a metabolic disorder leading to a deficiency in the metabolism of phenylalanine (Phe). Elevated Phe levels in the blood, tissue and brain may lead to emotional, cognitive, and physical symptoms in adults. To control blood Phe levels, most individuals with PKU need to follow a strict, life-long Phe-restricted diet. The main objective of this study was to estimate the impact of PKU-related disease symptoms and dietary restrictions on health-related quality of life (HRQoL). This study was designed as a web-based survey using the methods of Time Trade-Off (TTO) and Discrete Choice Experiment with duration (DCE
TTO
) in a survey of the Swedish general population and population with PKU. Data were collected using questionnaires for TTO diet (
n
= 509), TTO symptoms (
n
= 507), and DCE
TTO
(
n
= 1117). The disutility of diet restrictions ranged from 0.050 for a partially restricted diet without medical food to 0.193 for a fully restricted diet with medical food in the TTO (DCE: 0.043–0.108). The disutility of experiencing symptoms (emotional, cognitive and physical) ranged from 0.148 for mild symptoms to 0.593 for severe symptoms in the TTO (DCE: 0.122–1.522). The study shows that both diet and symptoms have a significant negative impact on HRQoL in PKU and that utility estimates are largely consistent across methods and samples.</description><subject>Blood</subject><subject>Diet</subject><subject>Dietary restrictions</subject><subject>Economic Policy</subject><subject>Health Care Management</subject><subject>Health Economics</subject><subject>Medical foods</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolic disorders</subject><subject>Original Paper</subject><subject>Pharmacoeconomics and Health Outcomes</subject><subject>Phenylketonuria</subject><subject>Public Finance</subject><subject>Public Health</subject><subject>Quality of life</subject><issn>1618-7598</issn><issn>1618-7601</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp9kcFu1zAMxisEEmPwApwiceFSlqRp2nBDE4NJk7iMc-SmDv-MNumSVNCX4VlJKdMkDpxs2T9_tvVV1WtG3zFKu4vEKFN9TTmrKROsrdWT6oxJ1tedpOzpQ96q_nn1IqU7SjnveHNW_bo9IXHzAiaT4Mn9CpPLGwmWTM7iHkeHmURMOTqTXfCJgB9LNSEkJGmblxzmUkwpGAcZR_LD5RNZTui36Tvm4Nfo4D0Bkt2MJEcYsQ7WPsiYiBmJOQVnkODPBWPBfCYpr-P2snpmYUr46m88r75efby9_FzffPl0ffnhpjZC8FxzacZuMA202AqG0nIFCgYGneHYtgp6A2oYlFLNMMrB2paqjppGGSspWNWcV28P3SWG-7U8q-dyGU4TeAxr0lxSIWQnxI6--Qe9C2v05bpCKS66XoimUPygTAwpRbR6KX9B3DSjerdMH5bpYpn-Y5nepckxhCZ4lx5HeqYkbVW36zYHkkrTf8P4uP0_wr8BU2Snsg</recordid><startdate>20220801</startdate><enddate>20220801</enddate><creator>Olofsson, Sara</creator><creator>Gralén, Katarina</creator><creator>Hoxer, Christina</creator><creator>Okhuoya, Paul</creator><creator>Persson, Ulf</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>OQ6</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>M0C</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PYYUZ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2609-2065</orcidid></search><sort><creationdate>20220801</creationdate><title>The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study</title><author>Olofsson, Sara ; Gralén, Katarina ; Hoxer, Christina ; Okhuoya, Paul ; Persson, Ulf</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-26cd7bc3a5e541e6f29a9ab1a7c2e559a8ca9bb9993bd6bff50970c39cf60af93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood</topic><topic>Diet</topic><topic>Dietary restrictions</topic><topic>Economic Policy</topic><topic>Health Care Management</topic><topic>Health Economics</topic><topic>Medical foods</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolic disorders</topic><topic>Original Paper</topic><topic>Pharmacoeconomics and Health Outcomes</topic><topic>Phenylketonuria</topic><topic>Public Finance</topic><topic>Public Health</topic><topic>Quality of life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Olofsson, Sara</creatorcontrib><creatorcontrib>Gralén, Katarina</creatorcontrib><creatorcontrib>Hoxer, Christina</creatorcontrib><creatorcontrib>Okhuoya, Paul</creatorcontrib><creatorcontrib>Persson, Ulf</creatorcontrib><collection>ECONIS</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Access via ABI/INFORM (ProQuest)</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Global</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ABI/INFORM Collection China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The European journal of health economics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Olofsson, Sara</au><au>Gralén, Katarina</au><au>Hoxer, Christina</au><au>Okhuoya, Paul</au><au>Persson, Ulf</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study</atitle><jtitle>The European journal of health economics</jtitle><stitle>Eur J Health Econ</stitle><date>2022-08-01</date><risdate>2022</risdate><volume>23</volume><issue>6</issue><spage>993</spage><epage>1005</epage><pages>993-1005</pages><issn>1618-7598</issn><eissn>1618-7601</eissn><abstract>Phenylketonuria (PKU) is a metabolic disorder leading to a deficiency in the metabolism of phenylalanine (Phe). Elevated Phe levels in the blood, tissue and brain may lead to emotional, cognitive, and physical symptoms in adults. To control blood Phe levels, most individuals with PKU need to follow a strict, life-long Phe-restricted diet. The main objective of this study was to estimate the impact of PKU-related disease symptoms and dietary restrictions on health-related quality of life (HRQoL). This study was designed as a web-based survey using the methods of Time Trade-Off (TTO) and Discrete Choice Experiment with duration (DCE
TTO
) in a survey of the Swedish general population and population with PKU. Data were collected using questionnaires for TTO diet (
n
= 509), TTO symptoms (
n
= 507), and DCE
TTO
(
n
= 1117). The disutility of diet restrictions ranged from 0.050 for a partially restricted diet without medical food to 0.193 for a fully restricted diet with medical food in the TTO (DCE: 0.043–0.108). The disutility of experiencing symptoms (emotional, cognitive and physical) ranged from 0.148 for mild symptoms to 0.593 for severe symptoms in the TTO (DCE: 0.122–1.522). The study shows that both diet and symptoms have a significant negative impact on HRQoL in PKU and that utility estimates are largely consistent across methods and samples.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><doi>10.1007/s10198-021-01415-9</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-2609-2065</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1618-7598 |
ispartof | The European journal of health economics, 2022-08, Vol.23 (6), p.993-1005 |
issn | 1618-7598 1618-7601 |
language | eng |
recordid | cdi_proquest_miscellaneous_2604467449 |
source | SpringerNature Journals |
subjects | Blood Diet Dietary restrictions Economic Policy Health Care Management Health Economics Medical foods Medicine Medicine & Public Health Metabolic disorders Original Paper Pharmacoeconomics and Health Outcomes Phenylketonuria Public Finance Public Health Quality of life |
title | The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T16%3A46%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20on%20quality%20of%20life%20of%20diet%20restrictions%20and%20disease%20symptoms%20associated%20with%20phenylketonuria:%20a%20time%20trade-off%20and%20discrete%20choice%20experiment%20study&rft.jtitle=The%20European%20journal%20of%20health%20economics&rft.au=Olofsson,%20Sara&rft.date=2022-08-01&rft.volume=23&rft.issue=6&rft.spage=993&rft.epage=1005&rft.pages=993-1005&rft.issn=1618-7598&rft.eissn=1618-7601&rft_id=info:doi/10.1007/s10198-021-01415-9&rft_dat=%3Cproquest_cross%3E2692478443%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2692478443&rft_id=info:pmid/&rfr_iscdi=true |